Reviva Pharmaceuticals I...
(RVPH)
undefined
undefined%
At close: undefined
2.69
2.48%
After-hours Dec 13, 2024, 07:59 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 23.37M | 18.52M | 29.69M | 8.76M | 193.00 | - |
| Short-Term Investments | - | - | - | - | 65.24M | 65.24M |
| Long-Term Investments | - | - | - | - | - | - |
| Other Long-Term Assets | - | - | - | 1.82K | 1.82K | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | 332.93K | 403.82K | 1.72M | 69.58K | - | - |
| Total Current Assets | 23.70M | 18.92M | 31.40M | 8.76M | 193.00 | 65.24M |
| Property-Plant & Equipment | - | - | - | - | 591.00 | - |
| Goodwill & Intangibles | - | - | - | - | - | - |
| Total Long-Term Assets | - | - | - | 1.82K | 2.41K | - |
| Total Assets | 23.70M | 18.92M | 31.40M | 8.76M | 2.60K | 65.24M |
| Account Payables | 3.85M | 3.52M | 509.58K | 1.01M | 224.54K | - |
| Deferred Revenue | - | - | - | - | 2.72M | - |
| Short-Term Debt | - | - | - | - | 3.77M | - |
| Other Current Liabilities | 13.33M | -1.00M | 1.33M | -683.35K | -123.02K | - |
| Total Current Liabilities | 17.18M | 6.04M | 2.34M | 1.33M | 6.81M | - |
| Long-Term Debt | - | - | - | - | - | - |
| Other Long-Term Liabilities | 806.65K | 567.44K | 372.73K | 2.96M | - | - |
| Total Long-Term Liabilities | 806.65K | 567.44K | 372.73K | 2.96M | - | - |
| Total Liabilities | 17.98M | 6.61M | 2.72M | 1.33M | 6.81M | 6.09M |
| Total Debt | - | - | - | - | 3.77M | - |
| Common Stock | 2.79K | 2.04K | 1.44K | 923.00 | 618.00 | - |
| Retained Earnings | -134.35M | -91.17M | -66.83M | -58.31M | -54.53M | - |
| Comprehensive Income | - | - | - | - | -54.53M | - |
| Shareholders Equity | 5.72M | 12.32M | 28.69M | 7.43M | -6.81M | - |
| Total Investments | - | - | - | - | 65.24M | 65.24M |